Full length articleCucurbitacin B purified from Ecballium elaterium (L.) A. Rich from Tunisia inhibits α5β1 integrin-mediated adhesion, migration, proliferation of human glioblastoma cell line and angiogenesis

Add time:08/18/2019    Source:sciencedirect.com

Integrins are essential protagonists in the complex multistep process of cancer progression and are thus attractive targets for the development of anticancer agents. Cucurbitacin B, a triterpenoid purified from the leaves of Tunisian Ecballium elaterium exhibited an anticancer effect and displayed anti-integrin activity on human glioblastoma U87 cells, without being cytotoxic at concentrations up to 500 nM. Here we show that cucurbitacin B affected the adhesion and migration of U87 cells to fibronectin in a dose-dependent manner with IC50 values of 86.2 nM and 84.6 nM, respectively. Time-lapse videomicroscopy showed that cucurbitacin B significantly reduced U87 cells motility and affected directional persistence. Cucurbitacin B also inhibited proliferation with IC50 value of 70.1 nM using Crystal Violet assay. Moreover, cucurbitacin B efficiently inhibited in vitro human microvascular endothelial cells (HMEC) angiogenesis with concentration up to 10 nM. Interestingly, we demonstrate for the first time that this effect was specifically mediated by α5β1 integrins. These findings reveal a novel mechanism of action for cucurbitacin B, which displays a potential interest as a specific anti-integrin drug.

We also recommend Trading Suppliers and Manufacturers of Cucurbitacin L (cas 1110-02-7). Pls Click Website Link as below: cas 1110-02-7 suppliers

Prev:Development and validation of a quantification method for cucurbitacins E and I in rat plasma: Application to population pharmacokinetic studies
Next:Optimized extraction of anti-cancer compound – cucurbitacin I and LC–MS identification of major metabolites from wild Bottle gourd (Lagenaria siceraria (Molina) Standl.))